In October 2019, Thierry Bernard provisionally took over the responsibilities of Qiagen CEO Peer Schatz, who had left the company unexpectedly after 27 years.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2020-04-01 12:16:342020-04-01 12:16:34Qiagen: Thierry Bernard remains CEO
https://european-biotechnology.com/wp-content/uploads/2024/04/FFG.jpg186270Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-04-01 09:06:542020-04-01 09:06:54Apeptico gets EU grant for COVID-19 drug
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2020-03-19_um_09.05.56.png362656Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-19 08:39:512020-03-19 08:39:51Experts discuss link between sepsis and Covid-19
https://european-biotechnology.com/wp-content/uploads/2024/04/Evonik.jpg8861181Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-03-18 05:38:002020-03-18 05:38:00Evonik Industries AG establishes production of recombinant collagen
Making opoids more effective pain killers
Latest NewsLow intrinsic efficacy can explain the reduced side effects of new agonists of the m-opioid receptor a British-Australian reseach team reports.
Qiagen: Thierry Bernard remains CEO
AppointmentsIn October 2019, Thierry Bernard provisionally took over the responsibilities of Qiagen CEO Peer Schatz, who had left the company unexpectedly after 27 years.
Apeptico gets EU grant for COVID-19 drug
Latest NewsAustrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients
CHMP greenlights Novartis’ Zolgensma
Latest NewsThe European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
New resource models human metabolism
Latest NewsScandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Novacyt inks contract on Covid-19 diagnostics
Latest NewsParis-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA gets Lilly milestone for Alzheimers’ candidate
Latest NewsAC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Experts discuss link between sepsis and Covid-19
Latest NewsScientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries AG establishes production of recombinant collagen
Latest NewsEvonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
BioNTech SE’s COVID-19 vaccine attracts investment
Latest NewsChinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.